Why is a low‑bicarbonate dialysate used during hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Low Bicarbonate Dialysate in Hemodialysis

Low bicarbonate dialysate is NOT routinely used in standard hemodialysis; rather, it is specifically employed in two distinct clinical scenarios: (1) to treat severe metabolic alkalosis, and (2) to enhance rapid potassium removal in life-threatening hyperkalemia.

Standard Practice: Higher Bicarbonate is the Norm

The question appears to reflect a misunderstanding of typical hemodialysis practice. Standard hemodialysis uses higher bicarbonate concentrations (32-38 mmol/L), not low bicarbonate 1. The K/DOQI guidelines explicitly recommend maintaining predialysis serum bicarbonate at or above 22 mmol/L, which is achieved through higher dialysate bicarbonate concentrations (38 mmol/L) or oral supplementation 1.

Why Higher Bicarbonate is Standard

Metabolic acidosis in dialysis patients causes:

  • Increased protein degradation and muscle catabolism
  • Decreased albumin synthesis
  • Oxidation of branched-chain amino acids
  • Worse nutritional status
  • Increased hospitalizations 1

Correction of acidosis improves serum albumin, decreases protein breakdown, and promotes better nutritional outcomes 1.

Specific Indications for Low Bicarbonate Dialysate

1. Severe Metabolic Alkalosis (pH ≥7.55)

When patients develop severe or extreme metabolic alkalosis, intermittent hemodialysis with low bicarbonate dialysate is highly effective for rapidly removing excess bases 2. This is a specialized intervention for:

  • Critically ill patients with pH ≥7.55
  • Extreme alkalosis (pH >7.6) associated with high mortality
  • Situations requiring prompt base removal

The alkalosis itself causes serious complications including increased adrenergic sensitivity, ionic hypocalcemia, hypokalemia, neuromuscular problems, and myocardial/cerebral ischemia 2.

2. Life-Threatening Hyperkalemia

High dialysate bicarbonate (39 mmol/L) produces faster potassium lowering compared to standard or low bicarbonate concentrations 3. However, this represents using higher bicarbonate, not lower. The mechanism involves enhanced intracellular potassium shift rather than increased dialytic removal 3.

Conversely, recent evidence suggests low bicarbonate dialysate may be used for extracorporeal CO2 removal, but this remains experimental 4.

3. Hemodynamic Instability During Dialysis

Low dialysate bicarbonate (30 mmol/L) compared to high bicarbonate (38 mmol/L) provides better hemodynamic stability during ultrafiltration 5. The 2024 study demonstrated:

  • Better preservation of blood pressure and stroke volume
  • Less decrease in cardiac output
  • Avoidance of alkalosis and hypocalcemia
  • Prevention of excessive hypokalemia 5

High bicarbonate dialysate causes transient metabolic alkalosis, hypocalcemia, and more pronounced hypokalemia, all contributing to hemodynamic instability 5.

Clinical Algorithm for Bicarbonate Management

For standard maintenance hemodialysis patients:

  1. Use dialysate bicarbonate 32-38 mmol/L 1
  2. Target predialysis serum bicarbonate ≥22 mmol/L 1
  3. Add oral sodium bicarbonate 2-4 g/day (25-50 mEq/day) if needed 1

For patients with intradialytic hypotension or hemodynamic instability:

  1. Consider lowering dialysate bicarbonate to 30 mmol/L 5
  2. Avoid high bicarbonate concentrations (>35 mmol/L) 5
  3. Monitor for adequate acid-base correction between sessions

For severe metabolic alkalosis (pH ≥7.55):

  1. Use low bicarbonate dialysate (specific concentration not standardized, but significantly below 30 mmol/L) 2
  2. Implement intermittent hemodialysis for rapid base removal 2
  3. Treat underlying cause simultaneously

Important Caveats

The 2006 K/DOQI guidelines note that use of low-potassium dialysate (1.0-1.5 mmol/L) worsens patient outcomes 6, though this refers to potassium, not bicarbonate. The principle remains: deviating from standard dialysate composition requires specific clinical justification.

Avoid confusing dialysate sodium with bicarbonate management—lower dialysate sodium concentrations are recommended for blood pressure control 7, but this is a separate issue from bicarbonate concentration.

The most recent high-quality evidence 5 suggests that in patients with hemodynamic instability, lower bicarbonate dialysate (30 mmol/L) may be preferable to high concentrations (38 mmol/L), representing a nuanced approach rather than routine use of "low" bicarbonate.

References

Research

The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005

Research

Hemodynamic effects of low versus high dialysate bicarbonate concentration in hemodialysis patients.

Hemodialysis international. International Symposium on Home Hemodialysis, 2024

Guideline

clinical practice guidelines for hemodialysis adequacy, update 2006.

American Journal of Kidney Diseases, 2006

Related Questions

What will happen if you dialyze a patient with severe metabolic alkalosis using a standard bicarbonate dialysate?
What is the appropriate oral sodium‑bicarbonate dosage for an adult patient, expressed in tablets or milligrams per day?
What is the maximum daily dose of oral sodium bicarbonate for an adult?
What is the appropriate oral sodium bicarbonate dose for an elderly nursing‑home patient, particularly if they have reduced renal function or heart failure?
How should I manage a patient with marked alkalemia (pH 7.61), severe respiratory alkalosis (PaCO₂ 16 mmHg), mild metabolic acidosis (bicarbonate 16.7 mmol/L, anion gap ~18), hypoxemia (PaO₂ 62 mmHg on room air, SpO₂ 96%) and normal lactate?
Based on an abdominal MRI showing a 4‑cm hypovascular solid mass at the pancreatic head‑body junction involving the mesenteric vessels and mild dilation of the distal main pancreatic duct and common bile duct, what is the likely diagnosis and what are the recommended next steps in management?
How should the mild neutropenia in a 16-year-old be interpreted?
What is the detailed macroscopic description of the different types of hernias?
How should a middle‑school‑aged child (≈11‑14 years) with recurrent seizures at school, the most recent lasting >15 minutes (status epilepticus), be managed acutely and long‑term?
Are there any drug‑drug interactions between Concerta (methylphenidate) and leflunomide, letrozole, Ibrance (palbociclib), folic acid, candesartan, hydrochlorothiazide, and risedronate?
What is the detailed microscopic description of the various types of hernias?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.